Experience

Davis Polk advised the joint book-running managers in connection with the $138 million initial public offering of common stock of Global Blood Therapeutics, Inc. Global Blood’s common stock…

Davis Polk advised MSCI Inc. (“MSCI”) in connection with a Rule 144A/Regulation S offering of $800 million aggregate principal amount of its 5.750% senior notes due 2025. The notes are…

Davis Polk advised CAR Inc. in connection its Regulation S offering of $300 million 6.00% senior notes due 2021. The notes are guaranteed by certain offshore subsidiaries of CAR Inc…

Davis Polk advised the joint book-running managers on an SEC-registered offering by Celgene Corporation of $8.0 billion aggregate principal amount of notes. The notes were issued in…

Davis Polk advised the underwriters in connection with the $183.9 million initial public offering of Aimmune Technologies, Inc. Aimmune Therapeutics sold 11,499,999 shares of its…

Davis Polk advised the joint book-running managers and representatives of the underwriters on an SEC-registered public debt offering by Airgas, Inc. of $400 million principal amount of its…

Davis Polk represents various subsidiaries of Comcast Corp. in four patent infringement lawsuits against Sprint Communications Co. LP pending in federal courts across the country. On August…

Davis Polk advised the managers and the global structuring agent and coordinator in connection with Intel’s SEC-registered offering in Taiwan of $1.0 billion aggregate principal amount of 4…

Davis Polk advised the underwriters in connection with the $251 million initial public offering of shares of common stock of Sunrun Inc. Of the shares sold in the offering, 17,482,268…

Davis Polk is advising affiliates of Kohlberg Kravis Roberts & Co. in connection with its $150 million investment into JBF Group that includes JBF Industries Limited and its…